RefleXion adds O’Shaughnessy as regulatory veep, Huntzinger as product Sr. director
RefleXion Medical said it appointed 18-year regulatory vet Kathy O’Shaughnessy as its new veep of clinical, regulatory and quality assurance and ex-Varian Medical senior director of medical affairs Calvin Huntzinger as its new senior director of products.
“RefleXion’s approach represents a significant advance for patients and uniquely leverages a proven modality for visualizing cancer with one of the most effective ways to treat cancer. I look forward to working with the company to bring BgRT into the clinic,” O’Shaughnessy said in a press release.
“RefleXion’s technology is one of the most significant radiation oncology innovations I have encountered in my long career in the oncology field. I am very excited about this new class of device that leverages a patient’s unique biology to personalize and tailor radiotherapy, which has the potential to improve treatments for cancer patients and their families,” Huntzinger said in prepared remarks.